Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:376087rdf:typepubmed:Citationlld:pubmed
pubmed-article:376087lifeskim:mentionsumls-concept:C0024299lld:lifeskim
pubmed-article:376087lifeskim:mentionsumls-concept:C0332437lld:lifeskim
pubmed-article:376087lifeskim:mentionsumls-concept:C0031437lld:lifeskim
pubmed-article:376087lifeskim:mentionsumls-concept:C0205470lld:lifeskim
pubmed-article:376087lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:376087lifeskim:mentionsumls-concept:C0868928lld:lifeskim
pubmed-article:376087lifeskim:mentionsumls-concept:C0439858lld:lifeskim
pubmed-article:376087pubmed:issue4lld:pubmed
pubmed-article:376087pubmed:dateCreated1979-8-29lld:pubmed
pubmed-article:376087pubmed:abstractTextIn order to test the immunologic validity of the Lukes-Collins (L-C) classification of the non-Hodgkin's lymphomas (ML), 60 ML in adult patients were studied and their B- or T-cell nature was predicted on a morphologic basis, without knowledge of the clinical history or the results of surface marker (SM) studies (SIg, C', Fc and E-rosettes), which were performed on cell suspensions and cryostat sections from the same specimens used for histology. There was a good correlation between morphologic types and SM (97% for the nodular ML, 81% for the diffuse). The predictions were not confirmed in 6 instances: one nodular ML typed as T; one convoluted lymphocytic ML typed as histiocytic; and four diffuse ML, predicted to be of B-type, bore no detectable SM ("Null" ML). It is concluded that the L-C morphologic criteria do allow in most cases the recognition of the B- or T-cell nature of ML, but cannot detect variations of the SM pattern which seem to affect the clinical behavior of these neoplasias. Thus, while the L-C classification seems immunologically sound, its clinical relevance still needs to be demonstrated.lld:pubmed
pubmed-article:376087pubmed:languageenglld:pubmed
pubmed-article:376087pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:376087pubmed:citationSubsetAIMlld:pubmed
pubmed-article:376087pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:376087pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:376087pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:376087pubmed:statusMEDLINElld:pubmed
pubmed-article:376087pubmed:monthAprlld:pubmed
pubmed-article:376087pubmed:issn0008-543Xlld:pubmed
pubmed-article:376087pubmed:authorpubmed-author:KerseyJ HJHlld:pubmed
pubmed-article:376087pubmed:authorpubmed-author:BloomfieldC...lld:pubmed
pubmed-article:376087pubmed:authorpubmed-author:Gajl-Peczalsk...lld:pubmed
pubmed-article:376087pubmed:authorpubmed-author:FrizzeraGGlld:pubmed
pubmed-article:376087pubmed:issnTypePrintlld:pubmed
pubmed-article:376087pubmed:volume43lld:pubmed
pubmed-article:376087pubmed:ownerNLMlld:pubmed
pubmed-article:376087pubmed:authorsCompleteYlld:pubmed
pubmed-article:376087pubmed:pagination1216-24lld:pubmed
pubmed-article:376087pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:376087pubmed:meshHeadingpubmed-meshheading:376087-H...lld:pubmed
pubmed-article:376087pubmed:meshHeadingpubmed-meshheading:376087-L...lld:pubmed
pubmed-article:376087pubmed:meshHeadingpubmed-meshheading:376087-A...lld:pubmed
pubmed-article:376087pubmed:meshHeadingpubmed-meshheading:376087-C...lld:pubmed
pubmed-article:376087pubmed:meshHeadingpubmed-meshheading:376087-L...lld:pubmed
pubmed-article:376087pubmed:meshHeadingpubmed-meshheading:376087-L...lld:pubmed
pubmed-article:376087pubmed:meshHeadingpubmed-meshheading:376087-A...lld:pubmed
pubmed-article:376087pubmed:meshHeadingpubmed-meshheading:376087-M...lld:pubmed
pubmed-article:376087pubmed:meshHeadingpubmed-meshheading:376087-P...lld:pubmed
pubmed-article:376087pubmed:meshHeadingpubmed-meshheading:376087-I...lld:pubmed
pubmed-article:376087pubmed:meshHeadingpubmed-meshheading:376087-T...lld:pubmed
pubmed-article:376087pubmed:meshHeadingpubmed-meshheading:376087-R...lld:pubmed
pubmed-article:376087pubmed:meshHeadingpubmed-meshheading:376087-B...lld:pubmed
pubmed-article:376087pubmed:meshHeadingpubmed-meshheading:376087-B...lld:pubmed
pubmed-article:376087pubmed:meshHeadingpubmed-meshheading:376087-R...lld:pubmed
pubmed-article:376087pubmed:meshHeadingpubmed-meshheading:376087-I...lld:pubmed
pubmed-article:376087pubmed:year1979lld:pubmed
pubmed-article:376087pubmed:articleTitlePredictability of immunologic phenotype of malignant lymphomas by conventional morphology: a study of 60 cases.lld:pubmed
pubmed-article:376087pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:376087pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:376087lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:376087lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:376087lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:376087lld:pubmed